Harnessing the Potential of Combination Immunotherapy and Oncolytic Virotherapy for Solid Tumors

Ann Surg Oncol. 2022 Feb;29(2):762-763. doi: 10.1245/s10434-021-11059-x. Epub 2021 Nov 26.

Authors

Sonia Cohen¹, Genevieve M Boland²

Affiliations

¹ Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
² Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, USA. [email protected].

PMID: 34837138
DOI: 10.1245/s10434-021-11059-x

No abstract available

Publication types

Editorial

MeSH terms

Humans
Immunotherapy
Neoplasms* / therapy
Oncolytic Virotherapy*
Oncolytic Viruses*